Implementing device-aided treatment strategies in advanced Parkinson's disease

Eric Freire-Alvarez, MD, University General Hospital of Elche, Elche, Spain, discusses the implementation of continuous dopaminergic delivery for the treatment of patients with Parkinson's disease. Device-aided therapies have been shown to reduce motor and non-motor complications in advanced PD patients. In the clinic, their initiation is sometimes delayed because motor and non-motor fluctuations are not recognized. To minimize the delay and ensure the optimal use of device-aided therapies, it is important these treatments are discussed early, well before the motor and non-motor symptoms have deteriorated excessively. This interview took place at the 2022 International Congress of Parkinson's Disease and Movement Disorders in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.